Mujie Kan
Impact in
- Molecular Medicine top 10%
- Hydrogels: synthesis, properties, applications
- Pharmacology top 10%
- Berberine and alkaloids research
- Alkaloids: synthesis and pharmacology
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Fibroblast Growth Factor Research 2
- Peroxisome Proliferator-Activated Receptors 1
- Epigenetics and DNA Methylation 1
-
- Berberine and alkaloids research 2
- Co-authors
- Li Chen (3 shared papers)Yue Pan (2 shared papers)Jing Li (2 shared papers)Xuewen Zhang (2 shared papers)Huiqing Xu (2 shared papers)Xi Yang (2 shared papers)Caina Xu (2 shared papers)Chang Liu (2 shared papers)
- Journals
- Applied Microbiology and Biotechnology (1 paper)Journal of Nanobiotechnology (1 paper)Acta Pharmacologica Sinica (1 paper)Molecules (1 paper)Materials Today Bio (1 paper)
- Partner nations
- ChinaCanadaSaint Kitts and Nevis
In The Last Decade
Mujie Kan
12 papers receiving 352 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 35
- Pharmacology 59
- Rehabilitation 36
- Pharmacology 83
- Biomaterials 59
Countries citing papers authored by Mujie Kan
This map shows the geographic impact of Mujie Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mujie Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mujie Kan more than expected).
Fields of papers citing papers by Mujie Kan
This network shows the impact of papers produced by Mujie Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mujie Kan. The network helps show where Mujie Kan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mujie Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 104 | |
| 2 | 2014 | 81 | |
| 3 | 2023 | 66 | |
| 4 | 2015 | 58 | |
| 5 | 2014 | 14 | |
| 6 | 2014 | 13 | |
| 7 | 2007 | 11 | |
| 8 | 2016 | 9 | |
| 9 | 2022 | 2 | |
| 10 | 2016 | 1 | |
| 11 | 2016 | 1 | |
| 12 | 2021 | 1 |
About Mujie Kan
Mujie Kan is a scholar working on Molecular Biology, Pharmacology, Pharmaceutical Science, Hematology and Cancer Research, having authored 12 papers that have together received 361 indexed citations. Recurring topics across this work include Berberine and alkaloids research (2 papers), Fibroblast Growth Factor Research (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Aquaculture disease management and microbiota (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Epigenetics and DNA Methylation (1 paper), SARS-CoV-2 detection and testing (1 paper) and Synthesis and Biological Activity (1 paper). The work is most often cited by research in Molecular Medicine (35 citations), Pharmacology (59 citations), Rehabilitation (36 citations), Pharmacology (83 citations) and Biomaterials (59 citations). Mujie Kan has collaborated with scholars based in China, Canada and Saint Kitts and Nevis. Frequent co-authors include Li Chen, Yue Pan, Jing Li, Xuewen Zhang, Huiqing Xu, Xi Yang, Caina Xu, Chang Liu, Xin Jiang and Yunjing Wang. Their work appears in journals such as Applied Microbiology and Biotechnology, Journal of Nanobiotechnology, Acta Pharmacologica Sinica, Molecules and Materials Today Bio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.